Ketamine for depression with suicidal thoughts in teens
Part of Mental health clinical trials.
This trial tests if a ketamine injection under the skin (subcutaneous) can safely help teenagers with severe depression and suicidal thoughts or actions. It is for teens who are already receiving standard depression treatment but still have high symptom scores.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 19 years old.
- You have been diagnosed with major depression (unipolar) and are currently getting treatment for it.
- You have had suicidal thoughts or made a suicide attempt in the past 30 days that needed emergency care.
- You score high on depression and suicide risk scales when evaluated by the study team.
- You do not have other conditions like autism, bipolar disorder, schizophrenia, or a history of substance abuse (including ketamine) in the last 6 months.
- You are not pregnant or breastfeeding (if female).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of ketamine, given through an IV, can quickly reduce suicidal thoughts in teenagers who come to the emergency department. It aims to find a faster way to help teens in crisis.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This trial tests if esketamine (a nasal spray) can quickly reduce symptoms of major depression and suicidal thoughts in teenagers who need urgent hospital care.
This Phase 3 study tests ketamine to reduce ongoing suicidal thoughts and help prevent another suicide attempt in youth after a recent attempt. It will compare ketamine treatment against standard care to see if it helps improve safety and reduce suicide risk.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This study tests how ketamine affects brain chemicals linked to suicidal thoughts in people with depression. You will receive ketamine and have brain scans (PET and MRI) to see if it changes activity in opioid receptors.
Hear when a new Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.